TGFB1 and TGFBR1 expression did not affect survival (data not shown), while TGFB2, TGFB3, TGFBR2, and TGBR3 overexpression decreased patient survival among ovarian cancer patients when the microarray data was assessed (Fig. 8A). This evidence concerns the gene TGFB1 and ovarian carcinoma.